Lisata Therapeutics (LSTA) Expected to Announce Quarterly Earnings on Thursday

Lisata Therapeutics (NASDAQ:LSTA) is expected to release its earnings data after the market closes on Thursday, February 27th. Analysts expect Lisata Therapeutics to post earnings of ($0.76) per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Lisata Therapeutics Stock Performance

LSTA opened at $2.48 on Tuesday. Lisata Therapeutics has a 52-week low of $2.19 and a 52-week high of $4.20. The stock has a market capitalization of $20.82 million, a P/E ratio of -0.99 and a beta of 1.14. The company’s 50-day simple moving average is $2.97 and its two-hundred day simple moving average is $2.93.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and set a $15.00 target price on shares of Lisata Therapeutics in a research report on Wednesday, December 11th.

About Lisata Therapeutics

Lisata Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease.